Certara Inc CERT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:35 PM EDT
16.27quote price arrow up+0.35 (+2.20%)
Volume
461,824
52 week range
11.81 - 22.65
Loading...
  • Open15.90
  • Day High16.32
  • Day Low15.64
  • Prev Close15.92
  • 52 Week High22.65
  • 52 Week High Date06/07/23
  • 52 Week Low11.81
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap2.617B
  • Shares Out160.84M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-7.62

KEY STATS

  • Open15.90
  • Day High16.32
  • Day Low15.64
  • Prev Close15.92
  • 52 Week High22.65
  • 52 Week High Date06/07/23
  • 52 Week Low11.81
  • 52 Week Low Date11/01/23
  • Market Cap2.617B
  • Shares Out160.84M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-7.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.39
  • P/E (TTM)-42.18
  • Fwd P/E (NTM)37.75
  • EBITDA (TTM)65.652M
  • ROE (TTM)-5.74%
  • Revenue (TTM)360.69M
  • Gross Margin (TTM)59.68%
  • Net Margin (TTM)-17.02%
  • Debt To Equity (MRQ)27.58%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Certara Inc

 

Profile

MORE
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and...
James Cashman III
Independent Chairman of the Board
William Feehery Ph.D.
Chief Executive Officer, Director
Leif Pedersen
President, Chief Commercial Officer
John Gallagher III
Chief Financial Officer, Senior Vice President
Address
4 Radnor Corporate Center, Suite 350
Radnor, PA
19087
United States

Top Peers

SYMBOLLASTCHG%CHG
AZTA
Azenta Inc
51.45-0.15-0.29%
NEO
Neogenomics Inc
14.89-0.24-1.55%
CDNA
CareDx Inc
14.80+0.02+0.14%
FLGT
Fulgent Genetics Inc
22.61+0.04+0.16%
OPK
OPKO Health Inc
1.30-0.05-3.70%